Related Experiment Video
Updated: Apr 3, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Insulin Pumps and Remote Software Updates: A New Way Forward
Noel E Schaeffer1, Linda J Parks2, Erik T Verhoef3
1Tandem Diabetes Care, Inc, San Diego, CA, USA nschaeffer@tandemdiabetes.com.
Insulin pump users desire smartphone-like software updates for their devices. Implementing optional, regulated updates can improve insulin pump technology and diabetes management.
Area of Science:
- Biomedical Engineering
- Medical Device Technology
- Diabetes Management
Background:
- Insulin pump technology is crucial for managing diabetes.
- Current software update processes for medical devices differ significantly from consumer electronics.
- Users expect seamless updates similar to smartphones and tablets.
Purpose of the Study:
- To explore user needs regarding insulin pump software updates.
- To propose a future direction for insulin pump software update systems.
- To align insulin pump technology with user expectations for ubiquitous technology.
Main Methods:
- User needs analysis.
- Literature review on current insulin pump technology and software update processes.
- Comparative analysis with smartphone update systems.
Main Results:
- Respondents desire insulin pump software updates mirroring smartphone update processes.
- Users expect optional updates for improvements and new features.
- A need exists for a regulated system enabling user-centric updates.
Conclusions:
- A user-centered, optional software update system is a viable future direction for insulin pumps.
- This approach can enhance diabetes management through improved pump technology and algorithms.
- Meeting user expectations can lead to better adoption and adherence to insulin pump therapy.
More Related Videos
Related Concept Videos
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Modified-Release Drug Delivery Systems: Rate-Programmed II
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

